We are live on ! Find out more
Allspring Global Investments

Allspring Global Investments Portfolio holdings

AUM $59.7B
1-Year Est. Return 29.08%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+29.08%
3 Year Est. Return
+84.39%
5 Year Est. Return
10 Year Est. Return
AUM
$62.5B
AUM Growth
+$2.15B
Cap. Flow
-$1.28B
Cap. Flow %
-2.05%
Top 10 Hldgs %
12.17%
Holding
2,934
New
176
Increased
1,192
Reduced
1,212
Closed
248

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$147M
2
KNX icon
Knight Transportation
KNX
+$140M
3
WY icon
Weyerhaeuser
WY
+$130M
4
FERG icon
Ferguson
FERG
+$108M
5
RH icon
RH
RH
+$99.8M

Top Sells

Rank Stock Value
1
DHI icon
D.R. Horton
DHI
+$276M
2
BLDR icon
Builders FirstSource
BLDR
+$178M
3
VYX icon
NCR Voyix
VYX
+$137M
4
LEA icon
Lear
LEA
+$105M
5
MSFT icon
Microsoft
MSFT
+$96.5M

Sector Composition

Rank Sector Weight
1 Technology 19.95%
2 Industrials 14.18%
3 Healthcare 11.6%
4 Financials 10.94%
5 Consumer Discretionary 10.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBLX icon
2676
Roblox
RBLX
$25.4B
$362 ﹤0.01%
9
-26
-74% -$1.04K
PRTS icon
2677
CarParts.com
PRTS
$51.3M
$361 ﹤0.01%
9
-809
-99% -$36.2K
IAS
2678
DELISTED
Integral Ad Science
IAS
$341 ﹤0.01%
+19
New +$321
AZPN
2679
DELISTED
Aspen Technology Inc
AZPN
$335 ﹤0.01%
2
-109
-98% -$20.2K
VTS icon
2680
Vitesse Energy
VTS
$685M
$291 ﹤0.01%
13
-2,492
-99% -$52K
TNL icon
2681
Travel + Leisure Co
TNL
$4.58B
$282 ﹤0.01%
7
-19,921
-100% -$767K
ABUS icon
2682
Arbutus Biopharma
ABUS
$907M
$218 ﹤0.01%
+95
New +$247
ONIT
2683
Onity Group
ONIT
$321M
$209 ﹤0.01%
7
GSAT icon
2684
Globalstar
GSAT
$10.8B
-2,388
Closed -$38.3K
MCRB icon
2685
Seres Therapeutics
MCRB
$47.4M
-99
Closed -$10.8K
ABCL icon
2686
AbCellera Biologics
ABCL
$3.18B
-31,877
Closed -$240K
AKA icon
2687
a.k.a. Brands
AKA
$119M
-1,008
Closed -$6.59K
ALCO icon
2688
Alico
ALCO
$308M
-190
Closed -$4.6K
ALEC icon
2689
Alector
ALEC
$240M
-17,805
Closed -$110K
ALRM icon
2690
Alarm.com
ALRM
$2.72B
-1,348
Closed -$67.8K
ALTO icon
2691
Alto Ingredients
ALTO
$315M
-1,659,751
Closed -$2.49M
ALXO icon
2692
ALX Oncology
ALXO
$278M
-14,724
Closed -$66.6K
AMRC icon
2693
Ameresco
AMRC
$1.47B
-1,428
Closed -$70.3K
AMTB icon
2694
Amerant Bancorp
AMTB
$1.15B
-402
Closed -$8.75K
AREN icon
2695
Arena Group
AREN
$61.9M
-10,645
Closed -$45.2K
ARKO icon
2696
ARKO Corp
ARKO
$500M
-4,027
Closed -$34.2K
ARQT icon
2697
Arcutis Biotherapeutics
ARQT
$3.3B
-1,114,111
Closed -$12.3M
OPTU
2698
Optimum Communications Inc
OPTU
$227M
-225,326
Closed -$771K
AWI icon
2699
Armstrong World Industries
AWI
$7.75B
-202,073
Closed -$14.4M
AXTI icon
2700
AXT Inc
AXTI
$5.13B
-7,202
Closed -$28.7K

Similar funds

Allspring Global Investments's Q2 2023 Portfolio in Review

As of Q2 2023, Allspring Global Investments held 2,934 positions worth $62.5B, up 3.6% from $60.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Allspring Global Investments's Q2 2023 filing shows 176 new, 1,192 increased, 1,212 reduced and 248 closed positions. Its largest new stake was RH: 381,731 shares worth $126M. The largest sale was D.R. Horton, an estimated $276M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

  • Allspring Global Investments's largest Q2 2023 buy was RH: 381,731 shares worth $126M.
  • Allspring Global Investments added most to L3Harris in Q2 2023, an estimated $147M increase.
  • Allspring Global Investments's biggest Q2 2023 reduction was D.R. Horton, cutting an estimated $276M.
  • Allspring Global Investments fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2023, selling an estimated $68.6M.
  • Allspring Global Investments's ten largest holdings make up 12% of its $62.5B portfolio in Q2 2023.
  • Allspring Global Investments opened 176 new positions and closed 248 in Q2 2023.
  • Allspring Global Investments's portfolio value rose 3.6% quarter-over-quarter to $62.5B.

Based on Allspring Global Investments's 13F filing for Q2 2023, filed 18 Jul 2023.